Art

J-GLOBAL ID：201002275083541492   Reference number：10A1606339

Anatomical Therapeutic Chemical Classification/Defined Daily Does Systemを利用した注射用抗菌薬の使用量と緑膿菌耐性率

Author (9)： UMEMURA TAKUMI (公立陶生病院 薬剤部) ,  MOCHIZUKI TAKAHIRO (静岡県静岡がんセ 薬剤部) ,  MURAKI YUICHI (三重大 医 病院 薬剤部) ,  KATAYAMA TOSHIYA (四日市社会保険病院 薬剤部) ,  TAKI HISASHI (東名古屋病院 薬剤科) ,  OMAGARI NORIO (県立静岡がんセ 感染症内科) ,  YAMAGISHI YUKA (愛知医大 病院 感染制御部) ,  MIKAMO HIROSHIGE (愛知医大 病院 感染制御部) ,  MORI TAKESHI (名城大 薬)
Material： 日本環境感染学会誌  (Japanese Journal of Infection Prevention and Control)
Volume： 25  Issue： 6  Page： 376-382  Publication year： Nov. 25, 2010 
JST Material Number： L2576A  ISSN： 1882-532X  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： *classification ,...
Semi thesaurus term： *anatomical therapeutic chemical classification system with defined daily dosage ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=10A1606339&from=J-GLOBAL&jstjournalNo=L2576A") }}

JST classification (2)： Clinical application of antibacterial drugs  (GW17030D) ,  Clinical application of antibiotics acting on pathogenic organisms  (GX05030N)

Substance index (2)： Imipenem ,  Meropenem

Reference (19)：

• 1) Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, et al.; Infectious Diseases Society of America; Society for Healthcare Epidemiology of America: Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007; 44: 159-77.
• 2) Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH: The influence of inadequate of antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118: 146-55.
• 3) White AC Jr, Atmar RL, Wilson J, Cate TR, Stager CE, Greenberg SB: Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities and clinical outcomes. Clin Infect Dis 1997; 25: 230-9.
• 4) Rahal JJ, Urban C, Horn D, Freedman K, Segal-Maurer S, Maurer J, et al.: Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 1998; 280(14): 1233-7.
• 5) 小野祐志,上田恒平,渋谷豊克,徳永康行,清水潤三,東 考次:抗菌薬適正使用を目的としたカルバペネム系薬の使用許可制導入.環境感染誌 2007; 22(4): 286-93.

Terms in the title (4)： 注射用抗菌薬 ,  使用量 ,  緑膿菌 ,  耐性